Similar articles

• Evaluation and selection of activated carbon for hemoperfusion.

  Walker JM, Denti E, Van Wagenen R, Andrade JD. Walker JM, et al. Kidney Int Suppl. 1976 Dec;(7):S320-7. Kidney Int Suppl. 1976. PMID: 1070555 No abstract available.
• Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure.

  Chang TM. Chang TM. Kidney Int Suppl. 1975 Feb;(3):387-92. Kidney Int Suppl. 1975. PMID: 1099317 Review. No abstract available.
• The rationale for fixed-bed charcoal in hemoperfusion.

  Hill JB, Palaia FL, McAdams JL, Palmer PJ, Skinner JT, Maret SM. Hill JB, et al. Kidney Int Suppl. 1976 Dec;(7):S328-32. Kidney Int Suppl. 1976. PMID: 1070556 No abstract available.
• Short-term evaluation of charcoal hemoperfusion combined with dialysis in uremic patients.

  Winchester JF, Apiliga MT, Kennedy AC. Winchester JF, et al. Kidney Int Suppl. 1976 Dec;(7):S315-9. Kidney Int Suppl. 1976. PMID: 1070554 No abstract available.
• Hemoperfusion in 1981.

  Chang TM. Chang TM. Contrib Nephrol. 1982;29:11-22. doi: 10.1159/000406174. Contrib Nephrol. 1982. PMID: 7042197 Review.